Furthermore, mutations in PI3K or PTEN, a tumor suppressor that negatively regulates the PI3K/AKT pathway, have been shown to display close association with increased chemoresistance in various cancers, including prostate and endometrial cancers28. Here, AKT1 is linked to neoplasm.